Center Laboratories, Inc. (TPEX:4123)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
45.00
+1.20 (2.74%)
At close: Mar 2, 2026
14.34%
Market Cap 33.59B
Revenue (ttm) 1.57B
Net Income (ttm) 1.78B
Shares Out 746.53M
EPS (ttm) 2.28
PE Ratio 19.77
Forward PE n/a
Dividend 0.71 (1.63%)
Ex-Dividend Date Oct 3, 2025
Volume 11,918,043
Average Volume 3,289,133
Open 43.30
Previous Close 43.80
Day's Range 42.80 - 45.15
52-Week Range 29.12 - 45.15
Beta 0.32
RSI 69.47
Earnings Date Mar 17, 2026

About Center Laboratories

Center Laboratories, Inc., a pharmaceutical company, develops, manufactures, and sells pharmaceuticals in Taiwan and internationally. The company offers general medication pharmaceuticals comprising antipyretics and analgesics, bronchodilators, anti-inflammatory preparations, antihistamines, expectorants, narcotic antitussives and expectorants, gastrointestinal preparations, non-narcotic antitussives and expectorants, and other medicines. It also offers central nervous system medication consisting of treatments for cerebrovascular disease, deme... [Read more]

Sector Healthcare
Founded 1959
Country Taiwan
Stock Exchange Taipei Exchange
Ticker Symbol 4123
Full Company Profile

Financial Performance

In 2024, Center Laboratories's revenue was 1.62 billion, an increase of 16.06% compared to the previous year's 1.39 billion. Losses were -1.10 billion, 10.9% more than in 2023.

Financial Statements

News

There is no news available yet.